Premier (PINC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting will be held for shareholders to vote on a proposed merger in which shareholders will receive $28.25 per share in cash, with the company becoming a wholly owned subsidiary of Premium Parent, LLC, an affiliate of Patient Square Capital.
The board unanimously recommends approval, citing a 23.8% premium over the 60-day average share price and the certainty of all-cash consideration.
The merger is not subject to a financing condition; committed equity and debt financing totaling approximately $2.8 billion is in place.
If the merger is not consummated, the company will remain public, and termination fees may apply: $66.2 million by the company or $168.6 million by Parent under certain conditions.
Voting matters and shareholder proposals
Shareholders will vote on: (1) the merger agreement, (2) an advisory (non-binding) vote on executive compensation related to the merger, and (3) a proposal to adjourn the meeting if more votes are needed.
Approval of the merger requires a majority of outstanding shares; abstentions and broker non-votes count as votes against.
The board recommends voting FOR all proposals.
Board of directors and corporate governance
The board established a transaction committee of independent directors to oversee negotiations and recommend the merger.
The board and committee met extensively, considered strategic alternatives, and determined the merger maximizes shareholder value.
The board and committee received fairness opinions from Goldman Sachs and BofA Securities.
Latest events from Premier
- Q4 revenue up 3%, FY25 guidance targets $1.02B revenue, $1.28 EPS, excluding divestitures.PINC
Q4 202423 Jan 2026 - Q1 net income rose to $72.9M on $248.1M revenue, driven by a $57M legal settlement.PINC
Q1 202516 Jan 2026 - Technology-driven growth, new leadership, and capital returns support long-term value.PINC
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q2 loss driven by $126.8M impairment; guidance reaffirmed, adjusted EPS outlook raised.PINC
Q2 20259 Jan 2026 - AI-driven supply chain and shared services are key to transformative savings and future growth.PINC
Leerink’s Global Healthcare Conference 202518 Dec 2025 - Definitive merger agreement for $28.25/share cash buyout, board-approved, pending shareholder vote.PINC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong ESG focus.PINC
Proxy Filing1 Dec 2025 - Shareholders to vote on a $28.25 per share all-cash merger, unanimously backed by the board.PINC
Proxy Filing1 Dec 2025 - Acquisition by Patient Square Capital will take the company private, pending approvals.PINC
Proxy Filing1 Dec 2025